908 Devices to Participate in Upcoming Investor Conferences

Rhea-AI Summary

908 Devices (Nasdaq: MASS), a leading developer of handheld and desktop devices for chemical and biochemical analysis, announced its participation in two upcoming investor conferences. The company will host a fireside chat at the 2024 Leerink Partners Healthcare Crossroads Conference in Austin, Texas, on May 29 at 8:00 a.m. CT. Additionally, 908 Devices will present at the William Blair 44th Annual Growth Stock Conference in Chicago, Illinois, on June 4 at 10:40 a.m. CT. Live and archived webcasts of these events will be available on their website.

Positive

• 908 Devices is actively engaging with the investor community through upcoming high-profile conferences.
• Participation in the 2024 Leerink Partners Healthcare Crossroads Conference highlights the company's relevance in the healthcare sector.
• Presentation at the William Blair 44th Annual Growth Stock Conference showcases the company's growth potential.

Negative

• No new product releases or financial performance updates were mentioned in the announcement.
• Lack of detailed financial projections or specific business developments in the PR.

BOSTON--(BUSINESS WIRE)-- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences.

• 2024 Leerink Partners Healthcare Crossroads Conference, Austin, Texas
  Fireside chat on Wednesday, May 29 at 8:00 a.m. Central Time / 9:00 a.m. Eastern Time

• William Blair 44^th Annual Growth Stock Conference, Chicago, Illinois
  Presentation on Tuesday, June 4 at 10:40 a.m. Central Time / 11:40 a.m. Eastern Time

Interested parties may access a live and archived webcast of these sessions on the “Investors” section of the company website at: www.908devices.com.

About 908 Devices

908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240515771040/en/

Media

Barbara Russo

brusso@908devices.com

Investor

Carrie Mendivil

IR@908devices.com

Source: 908 Devices Inc.

FAQ

What conferences will 908 Devices participate in?

908 Devices will participate in the 2024 Leerink Partners Healthcare Crossroads Conference and the William Blair 44th Annual Growth Stock Conference.

When is the 908 Devices fireside chat at the Leerink Partners Healthcare Crossroads Conference?

The fireside chat is scheduled for May 29 at 8:00 a.m. Central Time.

What is the date and time for 908 Devices' presentation at the William Blair 44th Annual Growth Stock Conference?

The presentation will take place on June 4 at 10:40 a.m. Central Time.

Where can I access the webcasts of 908 Devices' investor conference sessions?

Live and archived webcasts will be available on the 'Investors' section of the 908 Devices website.